|
K-leaseDrug - K-lease The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Potassium Chloride
Strength -
8MEQ
Applicant -
SAVAGE LABS
New Drug Application (NDA) Number -
073398
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 28, 1992
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Savage Laboratories Inc Div Altana Inc
K-lease
K-lease 8meq Capsule, Extended Release; Oral
Minizide 0.5mg;eq 5mg Base Capsule; Oral Renese-r 2mg;0.25mg Tablet; Oral Curosurf 80mg/ml Suspension; Intratracheal Photofrin 75mg/vial Injectable; Injection Potassium Acetate In Plastic Container 2meq/ml Injectable; Injection Paskalium 500mg Capsule; Oral Potassium Aminosalicylate 100% Powder; Oral Paskalium 1gm Tablet; Oral K-lease 10meq Capsule, Extended Release; Oral NewDrugInformation |